Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105350-105350
Closed Access | Times Cited: 15

Showing 15 citing articles:

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Zhenling Liu, Huanhuan Chen, Lili Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 517
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 78
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 28
Contribution of Knoevenagel Condensation Products toward the Development of Anticancer Agents: An Updated Review
Ramya Tokala, Darshana Bora, Nagula Shankaraiah
ChemMedChem (2022) Vol. 17, Iss. 8
Closed Access | Times Cited: 35
Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors
Anton Frühauf, Martin Behringer, Franz‐Josef Meyer‐Almes
Molecules (2023) Vol. 28, Iss. 15, pp. 5686-5686
Open Access | Times Cited: 16
Naphthyl‐Based Chalcone Derivatives: A Multifaceted Player in Medicinal Chemistry
Priyanka Mahesha, Nitinkumar S. Shetty
ChemistrySelect (2024) Vol. 9, Iss. 19
Open Access | Times Cited: 2
Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents
Prashant Chaudhari, Aditya Ramchandra Nemade, Atul A. Shirkhedkar
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33384-33417
Open Access | Times Cited: 1
Development of benzaldehyde-pyrazoline hybrids for functionalization of polymers with fluorescent pendant moieties
Gheorghe Roman, Mihaela Bălan, Liviu Săcărescu
Anais da Academia Brasileira de Ciências (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 1
An ultrasound assisted synthesis of spirooxindolo-1,2,4-oxadiazoles via [3+2] cycloaddition reaction and their anti-cancer activity
Madhu Kanchrana, Bhargava Sai Allaka, Gamidi Rama Krishna, et al.
ARKIVOC (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 2
Design, in silico studies, synthesis, and in vitro anticancer assessment of new naphthylidene isoxazolidinedione derivatives
Neha Upadhyay, Kalpana Tilekar, Aditi Oak, et al.
Vietnam Journal of Chemistry (2024) Vol. 62, Iss. 2, pp. 217-226
Open Access
Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies
Abdullah Yahya Abdullah Alzahrani, Pratibha Gupta, Vijay Patil, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 2, pp. 375-391
Closed Access
Integrated molecular modeling and dynamics approaches revealed the mechanism of selective inhibition of HDAC6/8
Yaxin Li, Sisi Liu, Ximing Xu, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Closed Access | Times Cited: 1
(E)-2-Methoxy-4-(3-(4-Methoxyphenyl) Prop-1-en-1-yl) Phenol Suppresses Breast Cancer Progression by Dual-Regulating VEGFR2 and PPARγ
Na‐Yeon Kim, Hyo‐Min Park, Hee Pom Lee, et al.
Journal of Microbiology and Biotechnology (2023) Vol. 34, Iss. 2, pp. 240-248
Open Access | Times Cited: 1
MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-κB pathway
Na‐Yeon Kim, Hyo‐Min Park, Jae‐Young Park, et al.
BMB Reports (2023) Vol. 57, Iss. 5, pp. 244-249
Open Access | Times Cited: 1
Page 1

Scroll to top